Healthstream Stock Price, News & Analysis

HealthStream, Inc. (Nasdaq: HSTM) will hold a conference call on October 25, 2022, to discuss its third quarter 2022 financial results. The results, covering the quarter ended September 30, 2022, will be released after market close on October 24, 2022. The conference call is set for 9:00 a.m. ET on October 25 and will be accessible via webcast or telephone. A replay will be available on the company’s website for at least 30 days. HealthStream focuses on workforce development in the healthcare sector.

HealthStream (Nasdaq: HSTM) announced a virtual Investor Day on September 22, 2022, from 9:00 a.m. to 12:00 noon CT. CEO Robert A. Frist, Jr. and the management team will discuss the company’s growth in healthcare IT and share updates on operations and finances. The event will feature presentations from nine speakers and aims to outline HealthStream's future strategies. Registration is required to attend, and materials will be available on the company’s website for 90 days post-event.

HealthStream reported a 1% revenue increase to $65.6 million for Q2 2022, compared to $64.8 million in Q2 2021. Operating income fell by 14% to $3.0 million, while net income surged 26% to $3.1 million. EPS rose from $0.08 to $0.10. Adjusted EBITDA decreased by 10% to $13.1 million. The company acquired the remaining stake in CloudCME for $4 million in cash and $4.1 million in stock. HealthStream maintains 2022 revenue guidance between $267.5 million and $273.0 million.

HealthStream (NASDAQ: HSTM) announced a conference call to discuss its Q2 2022 financial results scheduled for July 26, 2022. The financial results will be released on July 25, 2022, after market close. The call will begin at 9:00 a.m. ET, providing insights into the company’s performance. Participants can join via a webcast or telephone, with registration required for the latter. The call will be archived on HealthStream's website for later access.

HealthStream (NASDAQ:HSTM) has completed the acquisition of CloudCME, enhancing its position in healthcare continuing education. Initially investing in CloudCME in March 2019, HealthStream now fully owns the leading SaaS application designed for managing continuing medical education (CME). This strategic move adds essential capabilities to their service offerings, including a user-friendly portal for CME management. The acquisition cost approximately $4.08 million in cash and shares. HealthStream expects this integration to advance their growth and improve healthcare quality.

HealthStream (HSTM) reported Q1 2022 revenues of $65.4 million, up 3% from Q1 2021. Operating income rose 22% to $4.0 million, and net income climbed 26% to $2.9 million with EPS at $0.09. Adjusted EBITDA reached $14.0 million, a 3% increase. The company announced an expansion of its share repurchase program by $10 million, following a previous $20 million completion. Additionally, there was a management change with Michael Collier promoted to Executive Vice President of Corporate Strategy & Development.

HealthStream, Inc. (Nasdaq: HSTM) will hold a conference call on April 26, 2022, to discuss its first quarter financial results for the period ending March 31, 2022. The results will be released after market close on April 25, 2022. The call will start at 9:00 a.m. ET, and can be accessed by phone or through a live audio webcast. HealthStream provides workforce and provider solutions aimed at improving healthcare outcomes by developing healthcare organizations' workforce capabilities.

HealthStream (Nasdaq: HSTM) has expanded its share repurchase program, authorizing up to an additional $10 million for repurchasing outstanding shares. This follows the prior $20 million repurchased since the program's inception on November 30, 2021. Repurchases will be conducted based on market conditions and regulatory compliance, with a termination date set for March 13, 2023, or once the budget is depleted. The program aims to enhance shareholder value through increased earnings per share.

HealthStream, Inc. (Nasdaq: HSTM) reported its financial results for Q4 and full year 2021. Fourth quarter revenues increased by 4% to $64.3 million, while operating loss was $0.5 million. For the year, revenues rose 5% to $256.7 million, but operating income decreased by 49% to $8.1 million. The CEO contributed $2.4 million in stock for employee shares, impacting net loss negatively. Adjusted EBITDA for Q4 was $12.0 million, up 12%. The company authorized a $20 million share repurchase program and acquired Rievent Technologies for $4 million. Full-year guidance for 2022 is $267.5 to $273.0 million in revenue.